GSK, Sanofi launching clinical trial of potential COVID-19 vaccine
Sanofi and GlaxoSmithKline say they are beginning human trials of a potential vaccine for COVID-19 after positive results from pre-clinical testing.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
